Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer. | Redox Biol | 2023 | 36963289 | PubTator, text mining | PubMed |
| The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design. | BMJ Open | 2023 | 36958777 | PubTator, text mining | PubMed |
| A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 36951997 | PubTator, text mining | PubMed |
| NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK. | J Cell Mol Med | 2023 | 36950803 | PubTator, text mining | PubMed |
| Updates and advances in pyruvate kinase deficiency. | Trends Mol Med | 2023 | 36935283 | PubTator, text mining | PubMed |
| Genetic susceptibility to severe COVID-19. | Infect Genet Evol | 2023 | 36934789 | PubTator, text mining | PubMed |
| IgSF11-mediated phosphorylation of pyruvate kinase M2 regulates osteoclast differentiation and prevents pathological bone loss. | Bone Res | 2023 | 36928396 | PubTator, text mining | PubMed |
| Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency. | Sci Rep | 2023 | 36927785 | PubTator, text mining | PubMed |
| Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver. | Sci Rep | 2023 | 36914879 | PubTator, text mining | PubMed |
| Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells. | Molecules | 2023 | 36903601 | PubTator, text mining | PubMed |
| Mechanisms of Long Non-Coding RNA in Breast Cancer. | Int J Mol Sci | 2023 | 36901971 | PubTator, text mining | PubMed |
| Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions. | Asian J Pharm Sci | 2023 | 36896445 | PubTator, text mining | PubMed |
| Targeted next-generation sequencing identifies eighteen novel mutations expanding the molecular and clinical spectrum of PKLR gene disorders in the Indian population. | Ann Hematol | 2023 | 36892591 | PubTator, text mining | PubMed |
| Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma. | Front Genet | 2023 | 36873946 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy. | Biomed Res Int | 2023 | 36865483 | PubTator, text mining | PubMed |
| 3PNMF-MKL: A non-negative matrix factorization-based multiple kernel learning method for multi-modal data integration and its application to gene signature detection. | Front Genet | 2023 | 36865387 | PubTator, text mining | PubMed |
| Oncolytic Avian Reovirus σA-Modulated Upregulation of the HIF-1α/C-myc/glut1 Pathway to Produce More Energy in Different Cancer Cell Lines Benefiting Virus Replication. | Viruses | 2023 | 36851737 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Mitapivat for sickle cell disease and thalassemia. | Drugs Today (Barc) | 2023 | 36847623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=15